Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04044391 · ClinicalTrials.gov registry record
Use of Magnetocardiography in Evaluation of Patients Going for Cardiac Catheterization
A clinical trial, sponsored by Genetesis.
- Terminated
- Registry status
- 101
- Enrollment target
NCT04044391: Clinical Trial study, sponsored by Genetesis.
NCT04044391 is a clinical trial that was terminated before completion, run by Genetesis. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04044391 was terminated before completion, sponsored by Genetesis.
- TERMINATED
- Registry status
- 101 participants
- Enrollment target
Study Summary
This is a multicenter, prospective trial to measure the test performance characteristics of the Magnetocardiography (MCG) CardioFlux cardiac diagnostic system in detecting clinically significant coronary artery obstruction in patients with symptoms of suspected acute coronary syndrome or who present with a failed stress test with the intention of treat with cardiac catheterization.
Primary Outcome
Assess accuracy of CardioFlux MCG (MCG-CF) and magnetic field map characteristics with findings of significant coronary artery stenosis ≥70% via angiography and/or via FFR of \<0.8 or via instant wave-free ratio (iFR) .
Interventions
- DIAGNOSTIC_TEST CardioFlux Magnetocardiograph
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2019-05-15 |
| Est. Completion | 2020-05-04 |
Why NCT04044391 stopped before completion
NCT04044391 is an observational study that tracks outcomes without assigning an intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which CardioFlux Magnetocardiograph is the first listed.
NCT04044391 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04044391 about?
NCT04044391 is a clinical study titled "Use of Magnetocardiography in Evaluation of Patients Going for Cardiac Catheterization". This is a multicenter, prospective trial to measure the test performance characteristics of the Magnetocardiography (MCG) CardioFlux cardiac diagnostic system in detecting clinically significant coronary artery obstruction in patients with symptoms of suspected acute coronary syndrome or who present...
What is the current status of trial NCT04044391?
This trial is currently terminated. The enrollment target is 101 participants. The study started on 2019-05-15. Estimated completion is 2020-05-04.
What interventions are being tested in trial NCT04044391?
The interventions under investigation include: CardioFlux Magnetocardiograph (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04044391?
This trial is sponsored by Genetesis, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI